Submit Manuscripts
Author Information
Subscribe/Renew
Email Alerts
Feedback
RSS Feed

About the Journal
Editorial Board & Staff

Interventions Homepage Imaging Homepage Interventions Homepage Imaging Homepage

ACC.org
Cardiosmart
Cardiosource
CVN
Imaging Library
JACC Imaging
JACC Interventions


2009 Appropriateness Criteria for Coronary Revascularization

Intensive Glycemic Control and the Prevention of Cardiovascular Events: Expert Consensus Document
cardiology careers collections past issues search home
     

J Am Coll Cardiol, 2006; 48:1519-1526, doi:10.1016/j.jacc.2006.06.058 (Published online 25 September 2006).
© 2006 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ben-Dor, I.
Right arrow Articles by Kornowski, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ben-Dor, I.
Right arrow Articles by Kornowski, R.

Potential Hazards and Technical Considerations Associated With Myocardial Cell Transplantation Protocols for Ischemic Myocardial Syndrome

Itsik Ben-Dor, MD, Shmuel Fuchs, MD and Ran Kornowski, MD, FACC*

Department of Cardiology, Rabin Medical Center, Petach Tikva, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel


Figure 1
View larger version (37K):

[in a new window]
  		Figure 1 Factors influencing cell therapy. EPCs = endothelial progenitor cells; FGF = fibroblast growth factor; G-CSF = granulocyte colony-stimulating factor; GM-CSF = granulocyte-macrophage colony-stimulating factor; HIF = hypoxia inducible factor; VEGF = vascular endothelial growth factor.

 

Figure 2
View larger version (106K):

[in a new window]
  		Figure 2 (A) Endomyocardium showing spread of injected methylene blue dye. (B) Gross pathology of cross-sectioned hearts injected with methylene-blue dye tracer. (C) Endocardial ecchymosis resulting from intramyocardial injection of methylene blue. (D and E) Epicardial staining with methylene blue.

 
 
  cardiology careers collections past issues search home